PRAXIS PRECISION MEDICINES, INC. Increase Decrease In Operating Lease Liability
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Increase Decrease In Operating Lease Liability of -$449.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$348.00K.
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$101.00K.
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$311.00K.
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for the quarter ending 2025-03-31 was -$303.00K.
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for fiscal 2025 was -$1.26M.
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for fiscal 2024 was -$1.13M.
- PRAXIS PRECISION MEDICINES, INC. increase decrease in operating lease liability for fiscal 2023 was -$1.00M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|
| 2026-06-30 | -$348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$449.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$101.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | -$1.26M 10-K · filed 2026-02-19 | ||
| 2025-06-30 | -$311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$614.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | -$303.00K 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | -$1.13M 10-K · filed 2026-02-19 | ||
| 2023-12-31 | -$1.00M 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |